/term/dividends-per-share/TSXV:ZYUS ZYUS Life Sciences (TSXV:ZYUS) Dividends per Share
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ZYUS Life Sciences Corp (TSXV:ZYUS) » Definitions » Dividends per Share

ZYUS Life Sciences (TSXV:ZYUS) Dividends per Share : C$0.00 (TTM As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is ZYUS Life Sciences Dividends per Share?

ZYUS Life Sciences's dividends per share for the three months ended in Mar. 2024 was C$0.00. Its dividends per share for the trailing twelve months (TTM) ended in Mar. 2024 was C$0.00. Its Dividend Payout Ratio for the three months ended in Mar. 2024 was 0.00. As of today, ZYUS Life Sciences's Dividend Yield % is 0.00%.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

For more information regarding to dividend, please check our Dividend Page.


ZYUS Life Sciences Dividends per Share Historical Data

The historical data trend for ZYUS Life Sciences's Dividends per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ZYUS Life Sciences Dividends per Share Chart

ZYUS Life Sciences Annual Data
Trend Dec21 Dec22 Dec23
Dividends per Share
- - -

ZYUS Life Sciences Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Dividends per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Competitive Comparison of ZYUS Life Sciences's Dividends per Share

For the Drug Manufacturers - Specialty & Generic subindustry, ZYUS Life Sciences's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ZYUS Life Sciences's Dividend Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, ZYUS Life Sciences's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where ZYUS Life Sciences's Dividend Yield % falls into.



ZYUS Life Sciences Dividends per Share Calculation

Dividends paid to per common share.


ZYUS Life Sciences  (TSXV:ZYUS) Dividends per Share Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

ZYUS Life Sciences's Dividend Payout Ratio for the quarter that ended in Mar. 2024 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Mar. 2024 )/ EPS without NRI (Q: Mar. 2024 )
=0/ -0.051
=N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ZYUS Life Sciences Dividends per Share Related Terms

Thank you for viewing the detailed overview of ZYUS Life Sciences's Dividends per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


ZYUS Life Sciences (TSXV:ZYUS) Business Description

Traded in Other Exchanges
Address
407 Downey Road, Unit 204, Saskatoon, SK, CAN, S7N 4L8
ZYUS Life Sciences Corp is a next-generation life sciences company engaged in scientific research and development in phyto-therapeutics, including cannabinoid and protein-based formulations. It is committed to delivering high-quality standardized therapeutic formulations that comply with Good Manufacturing Practices (GMP) to provide targeted relief for patients in Canada and globally.
Executives
John Michael Hyshka Senior Officer

ZYUS Life Sciences (TSXV:ZYUS) Headlines

No Headlines